Generic topiramate products approved in US
This article was originally published in Scrip
Executive Summary
As expected, the US FDA has granted several approvals for the first generic versions of Ortho-McNeil's (Johnson & Johnson) epilepsy drug, Topamax (topiramate) tablets, following the expiry of the six months of paediatric exclusivity attached to the Orange-Book listed '006 patent.